Skip to main content
Peter McSweeney, MD, Oncology, Denver, CO

PeterAMcSweeneyMD

Oncology Denver, CO

Hematologic Oncology

Physician

Dr. McSweeney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. McSweeney's full profile

Already have an account?

  • Office

    2065 Ash Street
    Denver, CO 80207
    Phone+1 303-916-3360

Summary

  • I am a specialist in HSCT and CAR T cell therapy. I have extensive clinical and research experience in the field of hematological malignancies.

Education & Training

  • University of Otago School of Medicine
    University of Otago School of MedicineClass of 1982

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 1999 - 2025
  • MT State Medical License
    MT State Medical License 2005 - 2010
  • WA State Medical License
    WA State Medical License 1994 - 2000
  • American Board of Internal Medicine Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Long Term Follow-up of Tandem Autologous-Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma  
    Parameswaran Hari, Brenda M Sandmaier, Pamela S Becker, Leona Holmberg, Damian J Green, Peter A McSweeney, David G Maloney, Thomas R Chauncey, Haematologica

Abstracts/Posters

  • KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients (Pts) With Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results of the Phase...
    Peter A. McSweeney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • Colorado Hospitals Navigating Blood Shortage Crisis
    Colorado Hospitals Navigating Blood Shortage CrisisJanuary 23rd, 2022
  • Perspective on the Changing CDC Guidance
    Perspective on the Changing CDC GuidanceJuly 30th, 2021